Palisade Bio PALI
NASDAQ PALI
$2.09 +0.04 (+2.20%)
At close: Sep 4, 2026 · 4:00 PM EDT

Palisade Bio (PALI) Operating Margin (QoQ) (2011 - 2020)

Analysis

Palisade Bio (PALI) Operating Margin (QoQ) (2011 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Palisade Bio 440.73 Mn 315.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -5.72 Mn
Sep 30, 2020 100,000.00
Jun 30, 2020 -4.06 Mn
Mar 31, 2020 5.22 Mn
Dec 31, 2019 -33,592.00
Sep 30, 2019 -6.07 Mn
Jun 30, 2019 7.40 Mn
Mar 31, 2019 -2.61 Mn
Dec 31, 2018 1.11 Mn
Sep 30, 2018 -8.25 Mn
Jun 30, 2018 9.32 Mn
Mar 31, 2018 -9.31 Mn
Dec 31, 2017 10.26 Mn
Sep 30, 2017 6.52 Mn
Jun 30, 2017 55,104.00
Mar 31, 2017 -10.47 Mn
Dec 31, 2016 13.21 Mn
Sep 30, 2016 -4.33 Mn
Jun 30, 2016 9.60 Mn
Mar 31, 2016 -7.53 Mn